Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dominique Jean-Pierre Mabire is active.

Publication


Featured researches published by Dominique Jean-Pierre Mabire.


Archive | 2001

Metabotropic glutamate receptor antagonists

Dominique Jean-Pierre Mabire; Marc Gaston Venet; Sophie Coupa; Alain Philippe Poncelet; Anne Simone Josephine Lesage


Journal of Medicinal Chemistry | 2005

Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.

Dominique Jean-Pierre Mabire; Sophie Coupa; Christophe Denis Adelinet; Alain Philippe Poncelet; Yvan Simonnet; Marc Gaston Venet; Ria Wouters; Anne Simone Josephine Lesage; Ludy Van Beijsterveldt; Francois Paul Bischoff


Journal of Medicinal Chemistry | 2005

4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains

Abdellah Benjahad; Martine Croisy; Claude Monneret; Emile Bisagni; Dominique Jean-Pierre Mabire; Sophie Coupa; Alain Philippe Poncelet; Imre Christian Francis Csoka; Jérôme Emile Georges Guillemont; Christophe Meyer; Koen Andries; Rudi Pauwels; Marie-Pierre de Béthune; Daniel M. Himmel; Kalyan Das; Eddy Arnold; Chi Hung Nguyen; David S. Grierson


Archive | 1997

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Marc Gaston Venet; Dominique Jean-Pierre Mabire; Jean Fernand Armand Lacrampe; Gerard Charles Sanz


Archive | 2001

Pyridinone and pyridinethione derivatives having hiv inhibiting properties

Jérôme Emile Georges Guillemont; Abdellah Benjahad; Dominique Jean-Pierre Mabire; Chi Hung Nguyen; David S. Grierson; Claude Monneret; Emile Bisagni; Gerard Charles Sanz; Laurence Françoise Bernadette Decrane


Journal of Medicinal Chemistry | 2004

4-benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents: optimization and in vitro evaluation against clinically important HIV mutant strains.

Abdellah Benjahad; Karine Courte; Jérôme Emile Georges Guillemont; Dominique Jean-Pierre Mabire; Sophie Coupa; Alain Philippe Poncelet; Imre Christian Francis Csoka; Koen Andries; Rudi Pauwels; Marie-Pierre de Béthune; Claude Monneret; Emile Bisagni; Chi Hung Nguyen; David S. Grierson


Bioorganic & Medicinal Chemistry Letters | 2007

Structure-activity relationship in the 3-iodo-4-phenoxypyridinone (IOPY) series: The nature of the C-3 substituent on anti-HIV activity.

Abdellah Benjahad; Said Oumouch; Jérôme Guillemont; Elisabeth Thérèse Jeanne Pasquier; Dominique Jean-Pierre Mabire; Koen Andries; Chi Hung Nguyen; David S. Grierson


Archive | 2009

Quinoline and quinolinone derivatives, preparation process thereof and pharmaceutical compositions comprising them

Dominique Jean-Pierre Mabire; Marc Gaston Venet; Sophie Coupa; Alain Philippe Poncelet; Anne Simone Josephine Lesage


Archive | 2004

2-quinolinones 6-substituees et 2-quinoxalinones utilisees comme inhibiteurs de la poly(adp-ribose) polymerase

Dominique Jean-Pierre Mabire; Jérôme Emile Georges Guillemont; Dun Jacobus Alphonsus Josephus Van; Maria Victorina Francisca Somers; Walter Wouters


Archive | 2004

2-quinolinones et 2 quinoxalinones a substitution 7-phenylalkyl tenant lieu d'inhibiteurs de poly(adp-ribose) polymerase inhibitors

Dominique Jean-Pierre Mabire; Jérôme Emile Georges Guillemont; Dun Jacobus Alphonsus Josephus Van; Maria Victorina Francisca Somers; Walter Wouters

Collaboration


Dive into the Dominique Jean-Pierre Mabire's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge